View Older Stories View More Recent Stories

Sep 23, 2016 08:30AM Pfizer Announces Expiration of HSR Waiting Period For Proposed Acquisition of Medivation
Sep 22, 2016 11:56AM Pfizer Declares 30-Cent Fourth-Quarter 2016 Dividend
Sep 16, 2016 05:24PM Pfizer Announces Positive Top-Line Results from REFLECTIONS B537-02 Study for PF-06438179 (infliximab-Pfizer) a Potential Biosimilar to Remicade® (infliximab)
Sep 16, 2016 07:25AM Pfizer's (PFE) Ibrance Receives Positive EMA CHMP Opinion for Marketing in EU
Sep 16, 2016 07:24AM Pfizer Receives Positive CHMP Opinion For IBRANCE® (palbociclib) In Combination With Endocrine Therapy For The Treatment Of HR+/HER2- Metastatic Breast Cancer In Europe
Sep 15, 2016 08:33AM Pfizer (PFE), Merck (MRK) Announce Ertugliflozin Phase 3 Met Primary Endpoint in T2D
Sep 15, 2016 08:31AM Merck and Pfizer Announce Investigational Ertugliflozin Met Primary Endpoint of A1C Reduction When Added to Sitagliptin and Metformin in People with Type 2 Diabetes
Sep 15, 2016 06:29AM Pfizer (PFE) Announces FDA AdCom Recommendation to Remove Boxed Warning from CHANTIX
Sep 14, 2016 06:14PM FDA Advisory Committees Recommend to Remove Boxed Warning in Labeling for Pfizer’s Smoking Cessation Therapy, CHANTIX® (varenicline)
Sep 8, 2016 09:07AM AnTolRx, Inc. Announces Series A Equity Funding from Pfizer, JDRF and Orion Equity Partners, LLC to Develop Targeted Nanoparticle Tolerance Therapeutics
Sep 8, 2016 09:07AM AnTolRx, Inc. Announces Series A Equity Funding from Pfizer, JDRF and Orion Equity Partners, LLC to Develop Targeted Nanoparticle Tolerance Therapeutics
Aug 31, 2016 07:04AM Pfizer (PFE) Receives EC Approval for XALKORI as ROS1-Positive Advanced NDCLC Treatment
Aug 31, 2016 07:00AM XALKORI® (Crizotinib) Receives Approval In European Union For The Treatment Of Patients With ROS1-Positive Advanced Non-Small Cell Lung Cancer
Aug 24, 2016 06:05AM Pfizer (PFE) Enters Agreement to Acquire AstraZeneca's (AZN) Small Molecule Anti-Infective Business in ~$1.58B Deal
Aug 24, 2016 02:00AM Pfizer to Acquire Small Molecule Anti-Infective Business from AstraZeneca
Aug 23, 2016 07:00AM Bristol-Myers Squibb (BMY), Pfizer (PFE) Will Present New Eliquis Data at ESC Congress 2016
Aug 23, 2016 06:59AM Bristol-Myers Squibb and Pfizer to Present New Eliquis (apixaban) Analyses at ESC Congress 2016
Aug 22, 2016 06:46AM Pfizer to Acquire Medivation
Aug 22, 2016 06:45AM Pfizer (PFE) to Acquire Medivation (MDVN) in $14B Deal
Aug 22, 2016 06:45AM Pfizer To Acquire Medivation
Aug 22, 2016 06:44AM Pfizer (PFE) Announces FDA Approval of TROXYCA ER for Pain Management
Aug 19, 2016 06:21PM FDA Approves TROXYCA® ER (oxycodone hydrochloride and naltrexone hydrochloride) Extended-Release Capsules CII with Abuse-Deterrent Properties for the Management of Pain
Aug 8, 2016 08:00AM Pfizer Announces Publication of New Analysis Showing Long-Term Therapy with VYNDAQEL (tafamidis) Slowed Progression of Rare Neurodegenerative Disease
Aug 1, 2016 10:03AM Pfizer (PFE) Acquires Bamboo Therapeutics for $150M Plus $495M Contingent
Aug 1, 2016 10:00AM Pfizer Aims to Become Industry Leader in Gene Therapy with Acquisition of Bamboo Therapeutics, Inc.
Jul 28, 2016 04:10PM Pfizer Announces Positive Top-Line Results from Pivotal Phase 3 Maintenance Trial of Oral XELJANZ® (Tofacitinib Citrate) in Ulcerative Colitis
Jul 28, 2016 10:02AM Pfizer (PFE), Western Oncolytics Enter Immuno-Oncology Research Collaboration
Jul 28, 2016 10:00AM Pfizer and Western Oncolytics Announce Immuno-Oncology Research Collaboration to Investigate Novel Oncolytic Virus Technology
Jul 27, 2016 09:26AM Pre-Open Stock Movers 07/27: (SQNM) (LOGI) (AAPL) Higher; (GMED) (AKAM) (TWTR) Lower (more...)
Jul 26, 2016 06:17PM After-Hours Stock Movers 07/26: (LOGM) (AAPL) (EW) Higher; (TWTR) (AKAM) (MTCH) Lower (more...)
Jul 25, 2016 08:33AM Spark Therapeutics (ONCE), Pfizer (PFE) Offer Updated SPK-9001 Phase 1/2 Data in Hemophilia B
Jul 25, 2016 08:30AM Spark Therapeutics and Pfizer Announce Updated Data from First Cohort in Hemophilia B Phase 1/2 Trial Demonstrating Consistent, Sustained Therapeutic Levels of Factor IX Activity
Jul 21, 2016 07:32AM Spark Therapeutics (ONCE), Pfizer (PFE) Receive FDA Breakthrough Therapy Designation for SPK-9001 as Hemophilia B Treatment
Jul 21, 2016 07:30AM Spark Therapeutics and Pfizer Announce Receipt of FDA Breakthrough Therapy Designation for SPK-9001 for the Treatment of Hemophilia B
Jul 19, 2016 08:02AM Pfizer's (PFE) Prevenar 13 Receives WHO Prequalification for Four-Dose MDV
Jul 19, 2016 08:00AM Pfizer Receives World Health Organization Prequalification for Multi-Dose Vial Presentation of Prevenar 13®
Jul 13, 2016 08:14AM Pfizer (PFE) Announces Data from Two Pivotal Phase 3 Studies of Crisaborole Topical Ointment Published in JAAD
Jul 13, 2016 08:00AM Pfizer Announces the Publication of Final Results from Two Pivotal Phase 3 Studies of Crisaborole Topical Ointment in Patients with Mild to Moderate Atopic Dermatitis
Jul 12, 2016 04:05PM Pfizer (PFE) Prevnar 13 Granted FDA Approval for Ages 18-49
Jul 12, 2016 04:04PM Pfizer Receives FDA Approval for Prevnar 13® in Adults Age 18 Through 49
Jul 8, 2016 08:02AM Pfizer's (PFE) SUTENT Phase 3 Met Primary Endpoint
Jul 8, 2016 08:00AM Pfizer Announces Positive Top-Line Results From Phase 3 S-TRAC Trial of SUTENT® (sunitinib) as Adjuvant Therapy in Patients at High Risk of Recurrent Renal Cell Carcinoma
Jul 6, 2016 08:02AM Pfizer (PFE), Merck (MRK) Commence Aveluma Combo Phase 3 in Ovarian Cancer
Jul 6, 2016 08:00AM Merck and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer
Jul 6, 2016 08:00AM Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer
Jun 28, 2016 08:39AM Pfizer (PFE) Announces Two Additional Bococizumab Phase 3s Met Primary Endpoints
Jun 28, 2016 08:30AM Two Additional Phase 3 Lipid-Lowering Studies of Bococizumab Deliver Positive Topline Results
Jun 28, 2016 06:40AM Pfizer (PFE) Will Make $350M Investment in New, China-Located Global Biotechnology Center
Jun 27, 2016 11:30PM Pfizer Advances Biosimilars Leadership with Investment in a New World-Class Global Biotechnology Center in China
Jun 24, 2016 09:01AM Pfizer (PFE) Completes Acquisition of Anacor (ANAC)
View More Recent Stories View Older Stories